Wallace Eli M. 4
4 · BridgeBio Oncology Therapeutics, Inc. · Filed Oct 6, 2025
Insider Transaction Report
Form 4
Wallace Eli M.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-10-02+1,614,400→ 1,614,400 totalExercise: $12.44Exp: 2035-10-01→ Common Stock (1,614,400 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 2, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.